Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.
about
Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after strokeUse of mesenchymal stem cells for therapy of cardiac diseaseOver-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardiumTiming of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarctionDual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.DAPI diffusion after intravitreal injection of mesenchymal stem cells in the injured retina of rats.Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells.Activated omentum slows progression of CKD.Assessment and optimization of cell engraftment after transplantation into the heart.Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.The role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblastsOverexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H₂O₂ toxicity through cell survival protein activation.Wnt5a through noncanonical Wnt/JNK or Wnt/PKC signaling contributes to the differentiation of mesenchymal stem cells into type II alveolar epithelial cells in vitro.The wish to cure and the curiosity to investigate - or how I used my life to become a physician-scientist.Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis.Lipopolysaccharide pretreatment inhibits LPS-induced human umbilical cord mesenchymal stem cell apoptosis via upregulating the expression of cellular FLICE-inhibitory protein.Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo.Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart.Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction.Comparison of different adult stem cell types for treatment of myocardial ischemia.Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarctionMobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repairLipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironmentsRole of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction.Cell survival and redistribution after transplantation into damaged myocardium.Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technologyCellular cardiomyoplasty: what have we learned?Mesenchymal stromal cell and mononuclear cell therapy in heart disease.Mesenchymal stromal cells for cardiovascular repair: current status and future challenges.Mesenchymal stem cells in alleviating sepsis-induced mice cardiac dysfunction via inhibition of mTORC1-p70S6K signal pathway.Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction.Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical applicationBone marrow cell injection for chronic myocardial ischemia: the past and the futureIn vivo biodistribution of stem cells using molecular nuclear medicine imaging.
P2860
Q24642405-CA1D5BB7-1D38-4F39-AF14-50E100A35459Q27003127-20464BD1-6A6D-43DA-9B5B-D187100ED94BQ28576241-9C168707-D656-43EA-8D3C-5C3E4DA5E6E5Q30888146-3641B474-C23D-47A5-88C2-DDE9587B0C45Q33403153-39F9464E-D422-4520-A5A2-7EB1D7CED364Q33485022-CDAC0C69-656A-4050-81FA-FD946DEB698CQ33499506-6332D829-8AC6-44DE-A955-40657C5F9EFAQ33660533-FA9873C2-265C-4699-95D3-1411113A13C2Q33680007-A0B28213-3951-40DC-8342-B58A6E6AEBBCQ33835210-A728D3C4-612E-4687-BEAC-23225CB5D617Q33914944-DC58DE0C-1B06-4F5B-8E46-E325B35DEF13Q33926966-0FA0E6FE-99C5-44BC-9852-2C61AB2D1320Q34113375-641730AF-7595-42CA-8915-D48F0BF077D1Q34619825-58974B40-A021-45F4-BA90-1D4D8354CC28Q35127975-E6B8134C-FCC9-4822-B480-09608571AB89Q35153600-73B84AFF-4C47-4DA7-9687-F411E69991E8Q35524961-A610ED6A-317F-4A7A-BE9E-A24109ADC001Q35628589-463CFD94-8950-4838-A8B8-EC37DEDEE6B1Q35728777-77B0DC38-C200-4949-86FC-9C7CF8BAC371Q35767066-1B533002-F9B0-4D49-8E3F-C7B116F91D5EQ36294424-A47D9DEC-6501-4096-B96F-0E0A793412C6Q36733903-2FC5A010-5173-4492-A51D-368A72AC7687Q36772277-39DDE5DE-191F-48C9-B3FB-FBFDCF3E5C6AQ36853991-6800FF87-2AE4-48DB-AC55-17DE5F2F110EQ36920724-733493E2-7949-4019-8B94-3AB3B71E411DQ37167471-BBAA4FF5-8562-4D45-8F87-5CC8152AC73AQ37199481-8629ACDF-E2E3-41E8-8151-A97BBCF15307Q37213588-E9DB559F-3047-4F1E-BFF1-4AED0A1A0ADBQ37227786-E8ECC325-3966-4E81-894E-5103BD629ED9Q37294348-A0A95AB3-175F-4263-B3F3-39B805A33C98Q37336830-84F8F9EC-752A-43F5-AD78-B0D72F017119Q37337649-8554AAC4-A305-491F-99CC-4D96CA3FD35AQ37514676-5DA7DB02-9DD0-48C6-81F3-C5D0F4C1A9C5Q37608606-65F8206D-9478-44BF-9694-F714877D103DQ37626836-8731D52A-2388-4CE2-B277-0D7433FC4CBFQ37668484-46B6B110-DB8A-465A-B280-CDBE6B29C6E6Q37722141-EBCD9B07-14F2-457A-BAEE-3657A6295104Q37750922-195BD70F-1FC9-4614-938C-1AFBF8885A88Q37826666-3B2CA64C-06CC-4900-9E99-1BF819D523F1Q37853947-4B6560C8-6D36-4619-BABA-8FAABA3311EC
P2860
Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Effective engraftment but poor ...... nic rat myocardial infarction.
@en
Effective engraftment but poor ...... nic rat myocardial infarction.
@nl
type
label
Effective engraftment but poor ...... nic rat myocardial infarction.
@en
Effective engraftment but poor ...... nic rat myocardial infarction.
@nl
prefLabel
Effective engraftment but poor ...... nic rat myocardial infarction.
@en
Effective engraftment but poor ...... nic rat myocardial infarction.
@nl
P2093
P1476
Effective engraftment but poor ...... nic rat myocardial infarction.
@en
P2093
Benjamin Krausgrill
Bernd K Fleischmann
Jochen Müller-Ehmsen
Jochen W U Fries
Kerstin Schenk
Robert H G Schwinger
Uta C Neisen
Volker Burst
P304
P356
10.1016/J.YJMCC.2006.07.023
P577
2006-09-14T00:00:00Z